- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07942597
An AI-Powered Chatbot Targeting Nicotine and Cannabis Dual Vaping Cessation in Young Adults (D-QUIT)
An AI-Powered Chatbot Targeting Nicotine and Cannabis Dual Vaping Cessation in Young Adults (Aim 2)
A pilot study evaluates the feasibility and acceptability of D-QUIT, an AI-powered smartphone app providing personalized behavioral support for nicotine and cannabis vaping cessation among young adults.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Primary Objective:
I. To evaluate the feasibility and acceptability of D-QUIT, a smartphone app enhanced by an AI chatbot for vaping cessation.
Secondary Objective:
I. To assess intervention engagement and preliminary vaping cessation outcomes.
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Nhung Nguyen, PhD PharmD
- Telefonnummer: 877-827-3222
- E-post: VapingStudy@ucsf.edu
Studieorter
-
-
California
-
San Francisco, California, Förenta staterna, 94143
- University of California, San Francisco
-
Kontakt:
- Nhung Nguyen, PhD PharmD
- Telefonnummer: 877-827-3222
- E-post: VapingStudy@ucsf.edu
-
Huvudutredare:
- Nhung Nguyen, PhD PharmD
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Speak English.
- Ages 18-29.
- Live in California.
- Own a smartphone.
- Report vaping nicotine frequently (20+ days during the past month).
- Report vaping cannabis at least weekly.
- Intent to quit vaping nicotine in the next 30 days.
Exclusion Criteria:
- Younger than 18 years or older than 29 years of age.
- unable to read, speak, or understand English.
- Unwilling or unable to participate or give informed consent.
- Do not own a smartphone.
- have not vaped nicotine at least 20 days in the past month.
- Have not vaped cannabis at least weekly.
- Not thinking about quitting vaping within the next 30 days.
- Do not live in California.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: D-QUIT Pilot Intervention
Participants will use the D-QUIT smartphone app for 6 weeks to support their goals for quitting or reducing nicotine and cannabis vaping. During the 2 weeks before their nicotine vaping quit date, participants will receive app notifications to help identify vaping patterns and triggers, set goals, and learn coping skills. Beginning on the quit date, participants will receive tailored messages for 4 weeks with tips for managing withdrawal and support based on their vaping goals. Participants will also be encouraged to interact with the chatbot for 5-15 minutes daily and complete brief morning and end-of-day check-ins about vaping, cravings, mood, and withdrawal symptoms. At the end of the intervention, participants will complete a survey, and a subset will be invited to an interview to provide feedback on D-QUIT. |
A Smartphone App Enhanced by AI Chatbot Delivered Remotely via Mobile Phone Feasibility and Acceptability Measures administered at the end of 6-week intervention. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Feasibility of the D-QUIT Smartphone App
Tidsram: At Week 6
|
Feasibility will be assessed using the 4-item Feasibility of Intervention Measure (FIM). Each item is rated on a 5-point scale from 1 (Completely disagree) to 5 (Completely agree). Higher item scores indicate greater perceived feasibility of the intervention. Descriptive data will be reported. |
At Week 6
|
|
Acceptability of the D-QUIT Smartphone App
Tidsram: At Week 6
|
Acceptability will be assessed using the 4-item Acceptability of Intervention Measure (AIM). Each item is rated on a 5-point scale from 1 (Completely disagree) to 5 (Completely agree). Higher item scores indicate greater acceptability of the intervention. Descriptive data will be reported. |
At Week 6
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Intervention Engagement
Tidsram: At Week 6
|
Intervention engagement will be assessed using participants' duration of D-QUIT use (0-6 weeks) and the frequency of chatbot use during the intervention. Descriptive data will be reported. |
At Week 6
|
|
Preliminary Vaping-Cessation Outcomes
Tidsram: At Week 6
|
Preliminary vaping-cessation outcomes will be assessed using self-reported measures of nicotine and cannabis vaping, including the number of days vaped in the past 30 days or the number of quit attempts since starting D-QUIT. Use of other nicotine/tobacco and cannabis products will also be assessed. Descriptive data will be reported. |
At Week 6
|
Samarbetspartners och utredare
Samarbetspartners
Utredare
- Huvudutredare: Nhung Nguyen, PhD PharmD, University of California, San Francisco
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
- Beteende
- Rökning
- Hälsobeteende
- Användning av marijuana
- Rökning, icke-tobaksprodukter
- Vaping
- Rökavvänjning
- Marijuanarökning
- Sjukvårdskvalitet, tillgång och utvärdering
- Undersökningstekniker
- Epidemiologiska metoder
- Datainsamling
- Hälsovårdsutvärderingsmekanismer
- Hälsovårdskvalitet
- Folkhälsa
- Miljö och folkhälsa
- Undersökningar och frågeformulär
Andra studie-ID-nummer
- 26634
- T36IP10313 (Annat bidrag/finansieringsnummer: The California Tobacco Related Disease Research Program (TRDRP))
- NCI-2026-08289 (Registeridentifierare: NCI Clinical Trials Reporting System (CTRP))
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .